How funding from big pharma affects trial results

By Lucy Cormack
Updated March 8 2017 - 1:14pm, first published February 21 2017 - 3:31pm
A new study says drug industry-sponsored studies are more likely to deliver results and conclusions that favoured the sponsor. Photo: Erin Jonasson
A new study says drug industry-sponsored studies are more likely to deliver results and conclusions that favoured the sponsor. Photo: Erin Jonasson
A recent Cochrane review has revealed "definitive evidence" that pharmaceutical industry funding of drug studies biases results. Photo: Louie Douvis
A recent Cochrane review has revealed "definitive evidence" that pharmaceutical industry funding of drug studies biases results. Photo: Louie Douvis
Generic and non generic prescription prescription pharmaceuticals at John Bell Chemist, Woollarah. Pills, pharmacist, doctor, medical, health. Sunday 9th January 2011 AFR photo Louie Douvis job# 140519 Photo: Louie Douvis
Generic and non generic prescription prescription pharmaceuticals at John Bell Chemist, Woollarah. Pills, pharmacist, doctor, medical, health. Sunday 9th January 2011 AFR photo Louie Douvis job# 140519 Photo: Louie Douvis

Drug and device trial studies that are sponsored by the pharmaceutical industry are more likely to reveal statistical results and conclusions that favour a sponsor's product, a new Cochrane Library review has found.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options